Table 2.

Linear regression analysis of CAVI

	Age < 60 (N = 970)				Age 60‐79 (N = 3252)				Age ≥ 80 (N = 887)
	r	P	β	P	r	P	β	P	r	P	β	P
Age	0.45	<0.001	0.39	<.001	0.25	<.001	0.25	<.001	0.14	<.001	0.17	<.001
Male	0.18	<0.001	0.18	<.001	0.21	<.001	0.19	<.001	0.29	<.001	0.29	<.001
Body mass index	−0.28	<0.001	−0.21	<.001	−0.16	<.001	−0.20	<.001	−0.17	<.001	−0.15	<.001
Diabetes, glucose tolerance disorder	0.09	0.007	0.09	.017	0.19	<.001	0.16	<.001	0.12	<.001	0.06	.103
Dyslipidemia	0.05	0.157			−0.03	.066	−0.03	.111	−0.06	.059	0.01	.860
High‐normal normotension and grade I‐III hypertension	0.04	0.188			−0.01	.423			−0.07	.031	−0.05	.106
Smoking	0.12	<0.001	0.05	.136	0.07	<.001	0.03	.139	0.03	.305
Statin	0.06	0.074	0.01	.768	−0.02	.215			−0.06	.059	0.00	1.000
Antihypertensive medication	0.09	0.007	0.01	.855	−0.01	.635			−0.01	.788
Mean blood pressure	0.06	0.078	0.13	<.001	0.08	<.001	0.10	<.001	0.11	.001	0.15	<.001
Heart rate	−0.03	0.394			0.07	<.001	0.10	<.001	0.04	.225
LDL cholesterol	−0.19	<0.001	−0.08	.018	−0.05	.023	0.00	.880	0.03	.414
HDL cholesterol	0.03	0.441			−0.08	<.001	−0.04	.061	−0.01	.750
Glucose	0.14	<0.001	0.08	.039	0.20	<.001	0.08	<.001	0.11	.002	0.06	.141

Abbreviations: HDL, high‐density lipoprotein; LDL, low‐density lipoprotein.